Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
Clinical trial NCT03429543 · COMPLETED
Trial details
- NCT number
- NCT03429543
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2022-10-19
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.